Clinical Trial Update: Neutrophil Gelatinase Associated Lipocalin (NGAL) in Urine: Can This Prove to be a Biomarker for Acute Kidney Injury in Patients With Sepsis?

View source ↗

Summary

ClinicalTrials.gov update notes that a study evaluating urinary NGAL as a biomarker for acute kidney injury in patients with sepsis/septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis

Snippet

Sponsor: Sygehus Lillebaelt | Conditions: Severe Sepsis, Septic Shock | Status: COMPLETED